Heart failure & cardiomyopathies

Changes in Liver Function Tests, Congestion, and Prognosis After Acute Heart Failure: The STRONG-HF Trial

JACC AdvPublished study

Main finding · All-cause death or HF hospitalization, by baseline ALTResult — go to the resultHazard ratio 0.82 per log-unit 95% CI 0.66–1.01

Authors' conclusion

Lower ALT was associated with lower body mass index and more congestion in AHF, supporting previous studies suggesting ALT as a sarcopenia marker. The beneficial effect of HIC on health status was greater in low baseline ALT patients. (Safety, Tolerability and Efficacy of Rapid Optimization, Helped by NT-proBNP testinG, of Heart Failure Therapies [STRONG-HF]; NCT03412201).

Study context

Population
Acute heart failure (AHF) patients, liver function tests measured 1 to 2 days predischarge and after 90 days of high-intensity care (HIC) or usual care (UC)
Participants
1,062 AHF patients
Comparison
High-intensity care vs usual care
Outcome
all-cause death or HF hospitalization, by baseline ALT
Follow-up
180-day
Methodological detailsSTRONG-HF protocol
  • STRONG-HF protocol

Main finding

As reported in the abstract

Hazard ratio

0.82 per log-unit

95% CI 0.66–1.01

P = 0.06

ALT
HR 0.82 per log-unit (95% CI 0.66–1.01); P = 0.06

Per log-unit, as printed

Further findings

Baseline ALT, AST, and total bilirubin (tBil) · 1 to 2 days predischarge

ALT, median (Q1-Q3)
21 (15-32) U/L
AST, median (Q1-Q3)
23 (17-32) U/L
tBil, median (Q1-Q3)
14(10-21) umol/L

Baseline ALT and body mass index and congestion

Patients with lower ALT had lower body mass index
Patients with lower ALT, but not tBil or AST, were more likely to have edema, elevated jugular venous pressure, and orthopnea, and use more diuretics prerandomization

Change in ALT, AST, and tBil and congestion · 90 days

Greater reductions of ALT, AST, and tBil associated with greater improvement of edema, rales, NYHA functional class, and N-terminal pro-B-type natriuretic peptide

Change in AST, tBil and ALT, HIC vs UC · 90 days

HIC group had a greater reduction in AST and tBil than the UC group, while nonsignificant for ALT

Health status improvement from HIC by baseline ALT

Patients with lower ALT experienced greater health status improvement from HIC

Original publication

Changes in Liver Function Tests, Congestion, and Prognosis After Acute Heart Failure: The STRONG-HF Trial. JACC Adv. Published 21 February 2025. doi:10.1016/j.jacadv.2025.101607

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.